1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,540 | 0,595 | 12.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences unterzeichnet endgültige Vereinbarung zur Übertragung von Crown Bioscience an Adicon Holdings Limited | 435 | Business Wire | Strategische Transaktion positioniert Crown Bioscience für beschleunigtes Wachstum in der translationalen Onkologie
JSR Life Sciences LLC ("JSR Life Sciences"), ein weltweit führender Anbieter... ► Artikel lesen | |
| 13.11.25 | JSR Life Sciences to Transfer Crown Bioscience to Adicon Holdings Ltd. | 5 | Contract Pharma | ||
| 13.11.25 | EQS Newswire: Adicon Holdings Limited: Adicon to Acquire Crown Bioscience for US$204 Million, Creating a Global End-to-End Laboratory Service Platform | 380 | EQS Group (EN) | EQS Newswire / 13/11/2025 / 16:48 UTC+8
Hangzhou, China - Nov.13, 2025 - Adicon Holdings Limited ("Adicon", 9860.HK), a leading independent clinical laboratory service provider in China and a... ► Artikel lesen | |
| ADICON Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited | 440 | Business Wire | Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology
JSR Life Sciences LLC ("JSR Life Sciences"), a global leader in life sciences materials and services... ► Artikel lesen | |
| 13.11.25 | ADICON HOLDINGS (09860): MAJOR ACQUISITION - IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES OF THE TARGET COMPANY | 1 | HKEx | ||
| 04.09.25 | ADICON HOLDINGS (09860): 2025 INTERIM REPORT | 1 | HKEx | ||
| 22.08.25 | ADICON HOLDINGS (09860): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 22.08.25 | ADICON HOLDINGS (09860): APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEE | - | HKEx | ||
| 22.08.25 | ADICON HOLDINGS (09860): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
| 22.08.25 | ADICON HOLDINGS (09860): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 12.08.25 | ADICON HOLDINGS (09860): DATE OF BOARD MEETING | 3 | HKEx | ||
| 11.02.25 | EQS Newswire: Adicon Holdings Limited: Adicon Recognizes the Importance of Attracting and Retaining Talent Through its Incentive Plans | 335 | EQS Group (EN) | EQS Newswire / 11/02/2025 / 17:00 UTC+8
HANGZHOU, China (February 11, 2025) - Adicon Holdings Limited (the "Company," together with its subsidiaries, the "Group"), a leading independent clinical... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 39,010 | +3,94 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 119,24 | -11,92 % | GeneDx Holdings Corp. - 8-K, Current Report | ||
| FRESENIUS | 50,72 | +3,03 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +2,89 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,970 | +0,99 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| PROGYNY | 28,420 | +5,30 % | Progyny, Inc. - 8-K, Current Report | ||
| OUTSET MEDICAL | 5,570 | 0,00 % | Outset Medical, Inc.: Outset Medical Reports Unaudited Fourth Quarter and 2025 Results | SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis... ► Artikel lesen | |
| HEARTFLOW | 31,790 | -4,07 % | Heartflow, Inc. - 8-K, Current Report | ||
| ADAPTHEALTH | 10,600 | +1,05 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| BETA BIONICS | 17,620 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,180 | -0,19 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| GERRESHEIMER | 27,860 | +1,68 % | Gerresheimer-Aktie: Leerverkäufer im Fokus | ||
| RXSIGHT | 10,090 | +14,14 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,340 | -4,54 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen ADICON HOLDINGS LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +8,43 % bei einem Aktienkurs von 0,540 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADICON HOLDINGS LTD finden Sie auf Wallstreet Online.